Researchers develop a novel approach to monitor CD8⁺ T cell activity over time
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key…
Blood test shows promise for faster ALS diagnosis
New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis…
New advances improve cough detection in wearable health monitors
Researchers have improved the ability of wearable health devices to accurately detect when a patient is coughing, making…
Digital test plus blood biomarker boosts accuracy of Alzheimer’s diagnosis in primary care
By confirming cognitive impairment before ordering amyloid blood tests, this two-step approach cuts false positives, streamlines referrals, and…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Blood and brain biomarkers transform how doctors confirm Alzheimer’s disease
By integrating clinical assessment with cutting-edge biomarkers, researchers chart a practical pathway to faster and fairer Alzheimer’s diagnosis,…
Reticulocalbin-1 in clear cell renal cell carcinoma: clinical and functional evidence for its role as a biomarker and potential therapeutic target | BMC Cancer
Despite therapeutic advancements, the prognosis for metastatic ccRCC remains poor, with a 5-year survival rate of approximately 12–20…
electronRx to launch pDx app for remote chronic respiratory disease management
electronRx, a leading digital medicine and biomarker company driving healthcare through pulmonary innovation, today announced that it will…
UCL launches landmark trial of Alzheimer’s blood test
A major UCL-led clinical trial, aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test,…
Study identifies C1orf122 as prognostic marker in liver cancer
Primary liver cancer is the third leading cause of cancer-related deaths, of which hepatocellular carcinoma (HCC) accounts for…
SLIT2 protein levels in the eye and blood linked to cognitive function
Neurocognitive impairments are classified by pathological changes with potential for destruction of neural tissue. One change known to…
Blood-based biomarkers reveal barriers to diversity in Alzheimer’s disease trials
Some of the populations with the highest risk for Alzheimer’s disease remain greatly underrepresented in clinical trials-and a…